Trials / Not Yet Recruiting
Not Yet RecruitingNCT07338123
A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Through a prospective randomized controlled trial, we systematically evaluate the effects of Yiqi Huoxue Jiedu Formula combined with bacteriophage therapy on the bacterial clearance rate, disease improvement rate and mortality rate in patients with severe pneumonia caused by drug-resistant bacteria, so as to clarify its clinical transformation value.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YHDF Drug | 7-day treatment with YHDF Drug |
| DRUG | YHDF Placebo | 7-day treatment with YHDF placebo |
| DRUG | Bacteriophage | 7-14-day treatment with phage |
| DRUG | Bacteriophage Placebo | 7-14-day treatment with phage placebo |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2028-12-31
- Completion
- 2029-08-31
- First posted
- 2026-01-13
- Last updated
- 2026-01-13
Source: ClinicalTrials.gov record NCT07338123. Inclusion in this directory is not an endorsement.